NeutralLOW severityEarnings10h ago

XORTX THERAPEUTICS GAAP EPS of -$0.21

XORTX THERAPEUTICS GAAP EPS of -$0.21 — $XRTX one-month chart
$XRTX daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOK’s read

Health Care sector calm today, but $XRTX trades near its 52-week low, just a tenth away, after a sharp 1.92% drop. Recent coverage has been neutral, with attention concentrated in the last week, as the stock nears its yearly low.

Written by Wook AI Nov 17, 12:51 PM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about XRTX. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · xortx therapeuticsEvent risk Low

Nothing reported about xortx therapeutics across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 107% a year
Now $1.06Week $0.900–$1.22 (±15.1%)Month $0.733–$1.39 (±30.9%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: This one turns on a concrete figure ($0.21); set it against the recent trend before reading it as a turning point.
  • How the stock is trading: $XRTX +1.92% in the latest session.
  • Timing: It came out during market hours, so traders could react the same day, and the session move may reflect that.
Amount$0.21

Where the stock stands

XORTX Therapeutics ($XRTX) added 1.92% to $1.06 in the latest session. Over the past month it is up 5.0%. It now sits 71% under the 52-week high of $3.60 and 30% above the year's low of $0.82, close to the bottom of its range. It has been a volatile year: the high was 4.4 times the low, so moves this size are not unusual for it.

What the filings say

The company filed a 6-K — the form for material events — on Nov 16, 1 day before this story; it is $XRTX's own account and the first thing to read. Figures are as filed with the SEC; the $XRTX page has the full statements.

How much coverage it is getting

This is the only story on XORTX Therapeutics in Wook's last 30 days of coverage, so there is no recent run to compare it with.

The bigger picture

Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.

What to watch next

The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $XRTX page, and they say what management has disclosed without a reporter in between. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, at the top of the page, can work out how far $XRTX is from its high or compare this week's coverage with earlier weeks.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on November 17, 2026. $XRTX has moved +6.00% ($1.00 to $1.06). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy